Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock

International Immunopharmacology

Volumn 8, Issue 12, 2008, Pages 1616-1621

  Cruz, E A ^a   Da Silva, S A G ^a   Muzitano, M F ^a   Silva, P M R ^b   Costa, S S ^a   Rossi Bergmann, B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Anaphylaxis; Immunomodulation; Kalanchoe; Mouse

Indexed keywords

CYCLOSPORIN A; FLAVONOID; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 5; KALANCHOE PINNATA EXTRACT; OVALBUMIN; QUERCITRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYANOSIS; CYTOKINE PRODUCTION; DEATH; DRUG EFFICACY; DYSPNEA; EOSINOPHIL COUNT; HISTAMINE RELEASE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOSTIMULATION; KALANCHOE; LYMPHOCYTE PROLIFERATION; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REFLEX; SINGLE DRUG DOSE; SURVIVAL RATE; T LYMPHOCYTE; URTICARIA;

ANAPHYLAXIS; ANIMALS; CYTOKINES; EOSINOPHILIA; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; KALANCHOE; LYMPHOCYTE ACTIVATION; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN; PHYTOTHERAPY; PLANT EXTRACTS; QUERCETIN; RATS; TH2 CELLS;

EID: 54549113335     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.07.006     Document Type: Article

References (36)

1. Perry L.M., and Metzger J. Medicinal Plants of East Asia attributed properties and uses (1980), Mit Press 109-110
2. Nassis C.Z., Haebisch E.M., and Giesbrecht A.M. Antihistamine activity of Bryophyllum calycinum. Braz J Med Biol Res 25 (1992) 929-936
3. Pal S., and Chaudhuri N.A.K. Anti-inflammatory action of Bryophyllum pinnatum leaf extract. Fitoterapia 61 (1990) 527-533
4. Pal S., and Chaudhuri N.A.K. Studies on the anti-ulcer activity of a Bryophyllum pinnatum leaf extract in experimental animals. J Ethnopharmacol 33 (1991) 97-102
5. Supratman U., Fujita T., Akiyama K., Hayashi H., Murakami A., Sakai H., et al. Anti-tumor promoting activity of bufadienolides from Kalanchoe pinnata and K. daigremontiana × tubiflora. Biosci Biotechnol Biochem 65 (2001) 947-949
6. Yadav N.P., and Dixit V.K. Hepatoprotective activity of leaves of Kalanchoe pinnata Pers. J Ethnopharmacol 86 2-3 (2003) 197-202
7. Rossi-Bergmann B., Costa S.S., Borges M.B.S., Da-Silva S.A., Noleto G.R., Souza M.L.M., et al. Immunosuppressive effect of the aqueous extract of Kalanchoe pinnata in mice. Phytother Res 8 (1994) 399-402
8. Da-Silva S.A., Costa S.S., Mendonça S.C.F., Silva E.M., Moraes V.L.G., and Rossi-Bergmann B. Therapeutic effect of oral Kalanchoe pinnata leaf extract in murine leishmaniasis. Acta Tropica 60 (1995) 201-210
9. Almeida A.P., Da-Silva S.A., Souza M.L., Lima L.M., Rossi-Bergmann B., de Moraes V.L., et al. Isolation and chemical analysis of a fatty acid fraction of Kalanchoe pinnata with a potent lymphocyte suppressive activity. Planta Medica 66 (2000) 134-137
10. Muzitano M.F., Tinoco L.W., Guette C., Kaiser C.R., Rossi-Bergmann B., and Costa S.S. Assessment of antileishmanial activity of new and unusual flavonoids from Kalanchoe pinnata. Phytochemistry 67 (2006) 2071-2077
11. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 105 (2000) 399-408
12. Finkelman F.D. Anaphylaxis: lessons from mouse models. J All Clin Immunol. 120 (2007) 506-515
13. Muzitano M.F., Cruz E.A., Almeida A.P., et al. Quercitrin: an antileishmanial flavonoid glycoside from Kalanchoe pinnata. Planta Medica 72 (2006) 81-83
14. Rossi-Bergmann B., and Noleto G. A low-cost and efficient procedure for harvesting DNA-labeled cells using a dot-blot apparatus. Biotechniques 17 (1994) 678-680
15. De Oliveira Barreto E., Frias Carvalho V., Diaz B.L., et al. Adoptive transfer of mast cells abolishes the inflammatory refractoriness to allergen in diabetic rats. Int Arch Allergy Immunol 131 (2003) 212-220
16. Shore P.A., Burkhalter A., and Cohn V.H. A method for the fluorimetric assay of histamine in tissue. J Pharmacol Exp Ther 127 (1959) 182-186
17. Khan L.N., Kon O.M., Macfarlane A.J., Meng Q., Ying S., Barnes N.C., et al. Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin. Am J Respir Crit Care Med 162 (2000) 1377-1382
18. Dombrowicz D., and Capron M. Eosinophils, allergy and parasites. Curr Opin Immunol 13 (2001) 716-720
19. Kips J.C., O'Connor B.J., Langley S.J., Woodcock A., Kerstjens H.A., Postma D.S., et al. Effect of SCH55700, a humanized anti-human Interleukin-5 antibody, in severe persistent asthma. Am J Respir Crit Care Med 167 (2003) 1655-1659
20. Chen L., Martinez O., Overbergh L., Mathieu C., Prabhakar B.S., and Chan L.S. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 38 (2004) 375-387
21. Iwasaki M., Saito K., Takemura K., Sekikawa H., Fujii H., Yamada Y., et al. TNF-alpha contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 112 (2003) 134-140
22. Wu K., Bi Y.T., Sun K., and Wang C.Z. IL-10-Producing Type 1 regulatory T cells and allergy. Cell Mol Immunol 4 (2007) 269-275
23. Royer B., Varadaradjalou S., Saas P., Guillosson J.J., Kantelip J.P., and Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp All 31 (2001) 694-704
24. Kim S.H., Kim S.A., Park M., Kim S.H., Park Y.D., Na H.J., et al. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-a. Int Immunopharmacol 4 (2004) 279-287
25. Hong S.H., Jeong H.J., and Kim H.M. Inhibitory effects of Xanthii fructus extract on mast cell-mediated allergic reaction in murine model. J Ethnopharmacol 88 (2003) 229-234
26. Ueda Y., Oku H., Iinuma M., and Ishiguro K. Anti-anaphylactic and antipruritic effects of the flowers of Impatiens textori MIQ. Biol Pharm Bull 28 (2005) 1786-1790
27. Nyarko A.K., and Addy M.E. In-vitro screening for the anti-anaphylactic agent in Thonningia-sanguinea. J Ethnolpharmacol 41 (1994) 45-51
28. Kawai M., Hirano T., Higa S., Arimitsu J., Maruta M., Kuwahara Y., et al. Flavonoids and related compounds as anti-allergic substances. Allergol Int 56 (2007) 113-123
29. Lee E., Choi E.J., Cheong H., Kim Y.R., Ryu S.Y., and Kim K.M. Anti-allergic actions of the leaves of Castanea crenata and isolation of an active component responsible for the inhibition of mast cell degranulation. Arch Pharm Res 22 (1999) 320-323
30. Shaik Y.B., Castellani M.L., Perrella A., et al. Role of quercetin (a natural herbal compound) in allergy and inflammation. J Biol Reg Homeost Ag 20 (2006) 47-52
31. Walle T. Absorption and metabolism of flavonoids. Free Radical Biol Med 36 (2004) 829-837
32. Park S.Y., Kim J.H., and Kim D.H. Purification and characterization of quercitrin-hydrolyzing alpha-l-rhamnosidase from Fusobacterium K-60, a human intestinal bacterium. J Microbiol Biotechnol 15 (2005) 519-524
33. Comalada M., Camuesco D., Sierra S., et al. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35 (2005) 584-592
34. Alexander J., and Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 9 (2005) 17-23
35. Ramalingam T.R., Reiman R.M., and Wynn T.A. Exploiting worm and allergy models to understand Th2 cytokine biology. Curr Op All Clin Immunol 5 (2005) 392-398
36. Torres-Santos E.C., Da-Silva S.A.G., Santos A.P.P.T., Almeida A.P., Costa S.S., and Rossi-Bergmann B. Toxicological analysis and effectiveness of oral Kalanchoe pinnata on a human case of leishmaniasis. Phytother Res 17 (2003) 801-803